ASS1 and myelodysplastic syndrome: Patients with a high protein expression level of CD68, high level of iNOS, low level of ARG1, and negative ASS1 had a better prognosis, and iNOS and ARG1 are co‐expressed with CD68 in MDS patients with or without excess blasts, respectively.